Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test

International Journal of Epidemiology

Volumn 28, Issue 3, 1999, Pages 386-390

  Moss, S M ^a   Hardcastle, J D ^b   Coleman, D A ^a   Robinson, M H E ^c   Rodrigues, V C ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Proportional incidence; Screening; Sensitivity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESCENDING COLON; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TUMOR GROWTH; UNITED KINGDOM;

ADULT; AGED; COLONIC NEOPLASMS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; SIGMOID NEOPLASMS;

EID: 0033038326     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/28.3.386     Document Type: Article

References (11)

1. Chamberlain J, Clifford RD, Nathan BE, Price JL, Burn I. Error rates in screening for breast cancer. Clin Oncol 1979;5:135-46.
2. Day NE. Estimating the sensitivity of a screening test. J Epidemiol Community Health 1985;39:364-66.
3. Church TR, Ederer F, Mandel JS. Fecal occult blood screening in the Minnesota study: sensitivity of the screening test. J Natl Cancer Inst 1997;89:1440-48.
4. Day NE, Walter SD. Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 1984;40:1-14.
5. Launoy G, Smith TC, Duffy SW, Bouvier V. Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer 1997;73:220-24.
6. Gyrd-Hansen D, Sogaard J, Kronborg O. Analysis of screening data: colorectal cancer. Int J Epidemiol 1997;26:1172-81.
7. Robinson MHE, Moss SM, Hardcastle JD, Whynes DK, Chamberlain JO, Mangham CM. Effect of retesting with dietary restriction in Haemoccult screening for colorectal cancer. J Med Screening 1995; 2:41-44.
8. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O. Repeated screening for colorectal cancer with faecal occult blood test. Scand J Gastroenterol 1989;24:599-606.
9. Mandel JS. The University of Minnesota's colon cancer control study: design and progress to date. In: Chamberlain J, Miller AB (eds). Screening for Gastrointestinal Cancer. Stuttgart: Hans Huber Publishers, 1988, pp.17-24.
10. Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27 700 subjects. Cancer 1988;62:645-51.
11. Mandel JS, Bond JH, Church TR et al. For the Minnesota Colon Cancer Control Study. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.